Bioventus Focused on Double-Digit Growth and Debt Reduction Company Revenue The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year. May 17, 2022
Anika Gets Bounce from Order Timing in OA Pain Business Company Revenue The company grew in the low double digits for the first quarter of 2022 based on favorable order timing in its viscosupplement business. May 13, 2022
Globus Starts Slow But Reaffirms Guidance for 2022 Company Revenue The company grew in the low single digits for 1Q22 due to a tough comparison and a stagnant robotic sales pipeline. May 12, 2022
SeaSpine Attracting New Surgeons and Distributors in 2022 Company Revenue The company grew over 20% in the first quarter of 2022 as it wins over new surgeons and more exclusive distribution. May 11, 2022
NuVasive Grows Presence in Cervical and International Markets Company Revenue The company grew in the high single digits for 1Q22 as elective procedures returned to key markets in the second half of the quarter. May 09, 2022
Orthofix Sales Accelerated Late in First Quarter Company Revenue The company grew around 1% in 1Q22 on the strength of new product introductions and international stocking orders. May 09, 2022
Zimmer Biomet Beats Expectations for Early 2022 Company Revenue The company grew in the low single digits for 1Q22 as a strong recovery in elective procedures offset other headwinds. May 04, 2022
Smith+Nephew Welcomes Encouraging Start to 2022 Company Revenue The company grew in the low single digits for the first quarter and expects the orthopedic market's recovery to accelerate throughout 2022 May 03, 2022
Exactech Names Jeff Binder CEO Company Updates Jeffrey R. Binder, Exactech’s Chairman of the Board, is appointed Chief Executive Officer. Darin Johnson will continue in the role of President. Mar 31, 2022
Orthopedic Market Unlikely to Find Reprieve in 2022 Market Analysis Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022. Mar 23, 2022